A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/44079/132428_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | ![](/images/54719/135303_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| ![](/images/11887/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/11887/29435_B_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26174/58083_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/7912/1386_F6_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7912/24376_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53942/122039_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20280/153432_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20280/153432_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/45957/111687_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/19650/151980_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/46715/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16778/39552_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54684/126135_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/35625/149950_A_2_7_selected_60x60.jpg) | ![](/images/35625/71235_B_1_4_rna_selected_60x60.jpg) | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | Predicted intracellular proteins
| | ![](/images/54745/957_H1_4_selected_60x60.jpg) | | ![](/images/51816/143712_A_6_2_rna_selected_60x60.jpg) | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24256/55104_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12943/31347_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27499/60321_B_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| ![](/images/50769/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/50769/117204_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CA13 | Carbonic anhydrase XIII | Enzymes Predicted intracellular proteins
| | ![](/images/24689/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25567/53843_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10102/25628_B_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images/17258/ihc_cell_selected_60x60.jpg) | ![](/images/17258/40117_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/17107/39741_A_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/64258/1331_H7_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64258/144292_A_4_3_rna_selected_60x60.jpg) | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | ![](/images/51109/if_selected_60x60.jpg) | | ![](/images/51109/119163_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20398/109529_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9081/24280_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2146/5909_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/41307/490_E12_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41307/91314_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14361/33700_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15066/34421_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/52033/139611_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
DCHS2 | Dachsous cadherin-related 2 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/64159/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/64159/141447_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/17742/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17742/39381_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | ![](/images/44131/if_selected_60x60.jpg) | ![](/images/44131/ihc_cell_selected_60x60.jpg) | ![](/images/44131/97426_B_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| ![](/images/10703/ihc_selected_60x60.jpg) | ![](/images/10703/if_selected_60x60.jpg) | | ![](/images/10703/62773_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9426/25394_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45970/113237_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes Predicted intracellular proteins
| | ![](/images/39158/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39158/156571_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/26761/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26761/56007_A_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
EPN3 | Epsin 3 | Predicted intracellular proteins
| ![](/images/55546/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/55546/128756_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41851/88506_B_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43661/97673_B_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/5857/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/5857/18052_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/1451/ihc_cell_selected_60x60.jpg) | ![](/images/1451/4356_B_1_4_rna_selected_60x60.jpg) | Tissue enhanced |
FOXA2 | Forkhead box A2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| ![](/images/1388/3096_A_5_1_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/1388/3095_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46966/114458_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
FXYD3 | FXYD domain containing ion transport regulator 3 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/10856/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/10856/27898_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
GALNT5 | Polypeptide N-acetylgalactosaminyltransferase 5 | Enzymes Predicted intracellular proteins
| | ![](/images/9035/1368_G5_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/8963/24612_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |